Clinical Trial Update: Oral Absorbent and Probiotics in CKD Patients With PAD on Gut Microbiota, IncRNA, Metabolome, and Vascular Function [NA]

View source ↗

Summary

This Clinical Trial Update describes a study evaluating an oral absorbent and probiotics in chronic kidney disease patients with peripheral arterial disease, as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Peripheral Arterial Disease

Drugs mentioned

• Oral absorbent
• Probiotics

Snippet

Sponsor: National Taiwan University Hospital | Conditions: CKD, PAD - Peripheral Arterial Disease | NA | Status: RECRUITING